Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances
By: EMCDDA project leader, Roumen Sedefov
Contributors: European Monitoring Centre for Drugs and Drug Addiction; Council of the European Union
Series: EMCDDA risk assessments -- 8
Publisher: Office for Official Publications of the European Communities; Stationery Office, distributor
Published: 2009
Place of publication: Luxembourg; Norwich
Language: eng
Number of pages: 91
ISBN-13: 9789291683451
Subjects: Drug monitoring; Piperazine; Risk assessment; Psychotropic drugs; Stimulants; Drug abuse; Compuestos heterocíclicos; Toxicidad
Other titles: Report on the risk assessment of 1-benzylpiperazine in the framework of the Council decision on new psychoactive substances
Description: This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The risk assessment report examines the health and social risks of the drug, as well as information on international trafficking and the involvement of organized crime. Furthermore, the report considers the potential implications for placing the drug under control in the EU. On the basis of this report, as well as the initiative of the European Commission, the Council decided that BZP is to be subject to control measures.--Publisher's description.
Notes: "TD-AK-08-008-EN-C"--Back cover.

Includes bibliographical references.

Also freely available online.
Table of contents: title: Introduction; title: Council decision; title: Risk assessment report of a new psychoactive substance : 1-benzylpiperazine (BZP); title: Europol-EMCDDA joint report on BZP; title: Review of the pharmacotoxicological data on 1-benzylpiperazine (BZP); title: Criminological and sociological evidence and public health risks.